Orange, Sanofi, Capgemini and Generali announced plans to create a joint venture in France to fast-track the development of concrete healthcare solutions and to make them available to the market for the benefit of patients.
The project, on a scale that is unique in Europe, will bring together leading scientific and technological expertise in France and Europe. It will benefit from both a virtual platform and a physical base located in Paris. The founding partners are planning an initial investment of 24 million euros in the new entity, which will be operational from June 2021 for the virtual platform and December 2021 for the physical platform.
Digital innovation and data have become essential in healthcare. France and more broadly Europe have the necessary assets for large companies to capitalise on the innovation and agility of startups in order to jointly develop digital solutions that will bring value to patients and to the healthcare ecosystem. Work will focus on key themes for one or two years at a time and may revolve around a technology, a pathology, a patient population or be related to a public health topic. The new ecosystem, will bring together the 4 founding companies and aims to federate large companies and startups at a European level, around an open-innovation approach, conducive to the emergence of disruptive new models.
The founding companies will share and pool their technologies, expertise and data with selected startups, in compliance with regulations and within an ethical and responsible framework, to support the implementation of digital solutions that improve the quality, security, accessibility and productivity of healthcare.
Aiman Ezzat, CEO of Capgemini Group
As a global leader in digital technology, one of our major responsibilities for future generations is to put technology at the service of health. This is now a priority for Capgemini, which is proud to participate in this fine project.
Stéphane Richard, Chairman and CEO of Orange
By creating a multidisciplinary ecosystem bringing together major European groups and startups, we are providing ourselves with the means to accelerate the development of solutions for the benefit of both patients and caregivers.
